FindTrial
Sign In

Antibiotics for multidrug-resistant tuberculosis: network meta-analysis.

Antibiotics for multidrug-resistant tuberculosis: network meta-analysis. - Abx. for MDR-TB. NMA

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000039703
Enrollment
Unknown
Registered
2020-03-05
Start date
2020-03-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MDR-TB

Interventions

None listed

Sponsors

Yokohama City University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: MDR-TB

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
WHO 2008 defined outcomes. World Health Organization.Guidelines for the programmatic management of drug-resistant tuberculosis: emergency update 2008. 2008. Available at: Guidelines for the programmatic management of drug-resistant tuberculosis: emergency update 2008. Accessed on Mar 1st, 2020.—

Secondary

MeasureTime frame
Adverse effect. Time to culture conversion.—

Countries

Japan

Contacts

Public ContactNobuyuki Horita

Yokohama City University Department of Pulmonology

nobuyuki_horita@yahoo.co.jp045-787-2800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026